SL
ONC

Savior LLC’s BeOne Medicines Ltd ONC Stock Holding History

Savior LLC’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15
Closed -$5K – 828
2021
Q2 		$5K Hold
15
– – ﹤0.01% 587
2021
Q1 		$5K Hold
15
– – 0.01% 600
2020
Q4 		$4K Hold
15
– – ﹤0.01% 631
2020
Q3 		$4K Hold
15
– – ﹤0.01% 591
2020
Q2 		$3K Hold
15
– – ﹤0.01% 610
2020
Q1 		$2K Hold
15
– – ﹤0.01% 667
2019
Q4 		$2K Buy
+15
New +$2.49K ﹤0.01% 791

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Savior LLC's ONC Position: Q3 2021 in Review

Savior LLC sold out of BeOne Medicines Ltd (ONC) in Q3 2021, closing a stake of 15 shares — an estimated $5K sold.

Savior LLC first reported a position in ONC in Q4 2019 and held it in 7 quarters. The position peaked at $5K in Q2 2021. 254 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • Savior LLC reported no remaining BeOne Medicines Ltd position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 15 BeOne Medicines Ltd shares in Q3 2021, an estimated $5K.
  • Savior LLC first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 7 quarters.
  • Savior LLC's BeOne Medicines Ltd position peaked at $5K in Q2 2021.
  • 254 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.